Clinical trials
Terminated Epilepsy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 11 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 6 |
| Eisai Inc. | 4 |
| GlaxoSmithKline | 4 |
| Mayo Clinic | 3 |
| Neurocrine Biosciences | 3 |
| UCB Biopharma S.P.R.L. | 3 |
| Weill Medical College of Cornell University | 3 |
| Acorda Therapeutics | 2 |
| Columbia University | 2 |
| Emory University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 81 |
| Seizures | 29 |
| Drug Resistant Epilepsy | 9 |
| Epilepsies, Partial | 7 |
| Epilepsies, Myoclonic | 6 |
| Brain Diseases | 3 |
| Epilepsy, Temporal Lobe | 3 |
| Lennox Gastaut Syndrome | 3 |
| Nervous System Diseases | 3 |
| Status Epilepticus | 3 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.